Milestone Pharmaceuticals Inc. - Common Shares (NQ:MIST)

0.7642 -0.0152 (-1.95%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Milestone Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 Next >

Recap: Milestone Pharmaceuticals Q3 Earnings ↗

November 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 19, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023 ↗

June 20, 2023

Via Benzinga

Analyst Expectations for Milestone Pharmaceuticals's Future ↗

June 20, 2023

Via Benzinga

Expert Ratings for Milestone Pharmaceuticals ↗

May 23, 2023

Via Benzinga

Milestone Pharmaceuticals: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

Milestone Pharmaceuticals's Return On Capital Employed Overview ↗

March 30, 2023

Via Benzinga

Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 28, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 05, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 17, 2022

Gainers

Via Benzinga

Milestone Pharma Stock Surges After Successful Trial For Abnormal Heart Rhythm Candidate ↗

October 17, 2022

Via Benzinga

Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday ↗

October 18, 2022

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 17, 2022

Gainers Acorda Therapeutics (NASDAQ:ACOR) shares increased by 46.1% to $0.49 during Monday's pre-market session. The company's market cap stands at $11.9 million.

Via Benzinga

Splunk, Milestone Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

October 17, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 17, 2022

Good morning, investor! It's time to start off the trading week with a breakdown of the biggest pre-market stock movers on Monday!

Via InvestorPlace

Recap: Milestone Pharmaceuticals Q2 Earnings ↗

August 10, 2022

Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

Via Benzinga

This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday ↗

August 19, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.

Via Benzinga

Milestone Pharmaceuticals: Q1 Earnings Insights ↗

May 12, 2022

Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 22, 2022 ↗

April 22, 2022

Upgrades

Via Benzinga

Milestone Pharmaceuticals: Q4 Earnings Insights ↗

March 24, 2022

Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q4 earnings results on Thursday, March 24, 2022 at 07:20 AM. Here's what investors need to know about the...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 25, 2022

During Friday's trading, 54 companies set new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company by market cap to hit a new 52-week...

Via Benzinga

70 Biggest Movers From Yesterday ↗

November 16, 2021

Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 06, 2021

Gainers Opiant Pharmaceuticals (NASDAQ:OPNT

Via Benzinga

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More ↗

November 14, 2021

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at...

Via Benzinga

Week In Review: LianBio Acquires Two IBD Candidates In $218 Million Deal ↗

May 22, 2021

LianBio, a Princeton-Shanghai company, in-licensed Greater China rights for two inflammatory bowel disease candidates from Landos Biopharma. The $218 million deal includes $18 million upfront and $200...

Via Talk Markets

Milestone Pharma-Ji Xing Pharma Ink $127M Etripamil Development Agreement For China ↗

May 17, 2021

Milestone Pharmaceuticals Inc (NASDAQ: MIST) hit a major snag last March when its investigational etripamil nasal spray for episodes of rapid heart rate missed the...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 17, 2021

Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) shares increased by 20.68% to $1.4 during Monday's pre-market session. The market value of their outstanding shares is at...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.